版本:
中国

BRIEF-Ipsen says MHRA has approved a new indication for Decapeptyl

March 13 Ipsen Sa

* Ipsen announces mhra1 approval of new indication for Decapeptyl® for the treatment of pre-menopausal women with early stage breast cancer

* MHRA in UK, in coordination with fourteen other european regulatory agencies, has approved a new indication for Decapeptyl Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐